A serum inhibitor of immune regulation in patients with systemic lupus erythematosus.
AUTOR(ES)
Twomey, J J
RESUMO
Normal mononuclear leukocytes were incubated with serum from patients with active systemic lupus erythematosus (SLE) and healthy subjects and then studied on lymphoproliferative tests. Serum from SLE patients that contained an autoantibody to a subpopulation of thymus-derived (T) lymphocytes inhibited suppressor T-cell activity induced with concanavalin A. These sera did not inhibit lymphoproliferative responses or suppression by monocytoid cells. Mitogen-activated suppressor cells were not inhibited with serum from SLE patients or healthy subjects lacking T-cell autoantibody. This abnormality may contribute to the altered immune response that occurs with SLE.
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=371819Documentos Relacionados
- Tuberculosis in patients with systemic lupus erythematosus.
- Brain-reactive lymphocytotoxic antibodies in the serum of patients with systemic lupus erythematosus.
- Rheumatoid factor in patients with systemic lupus erythematosus.
- Specific concentration of polynucleotide immune complexes in the cryoprecipitates of patients with systemic lupus erythematosus.
- Peripheral vascular disease in patients with systemic lupus erythematosus.